These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 32230896

  • 1. Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.
    Papadia P, Micoli K, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N.
    Int J Mol Sci; 2020 Mar 27; 21(7):. PubMed ID: 32230896
    [Abstract] [Full Text] [Related]

  • 2. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1R,2R and 1S,2S enantiomers of the trans-1,2-diamino-4-cyclohexene ligand (DACHEX), an analogue of diaminocyclohexane used in oxaliplatin.
    Papadia P, Barbanente A, Ditaranto N, Hoeschele JD, Natile G, Marzano C, Gandin V, Margiotta N.
    Dalton Trans; 2021 Nov 09; 50(43):15655-15668. PubMed ID: 34673864
    [Abstract] [Full Text] [Related]

  • 3. New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity.
    Barbanente A, Iacobazzi RM, Azzariti A, Hoeschele JD, Denora N, Papadia P, Pacifico C, Natile G, Margiotta N.
    Molecules; 2021 Jun 04; 26(11):. PubMed ID: 34200051
    [Abstract] [Full Text] [Related]

  • 4. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N.
    Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands.
    Margiotta N, Savino S, Marzano C, Pacifico C, Hoeschele JD, Gandin V, Natile G.
    J Inorg Biochem; 2016 Jul 14; 160():85-93. PubMed ID: 26775068
    [Abstract] [Full Text] [Related]

  • 6. Platinum (II) complexes with stereochemically-defined thiepane dioxide diamine ligands as anticancer drugs.
    Cerè V, Grossi L, Munari D, Pollicino S, Martelli L, Martelli M.
    Anticancer Res; 2006 Jul 14; 26(3A):1815-9. PubMed ID: 16827112
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z, Chan HM, Li C, Wang Z, Tse MK, Tong Z, Zhu G.
    Inorg Chem; 2018 Jul 16; 57(14):8227-8235. PubMed ID: 29943979
    [Abstract] [Full Text] [Related]

  • 8. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity.
    Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H.
    Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585
    [Abstract] [Full Text] [Related]

  • 9. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs?
    Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D.
    J Med Chem; 2021 Aug 12; 64(15):11364-11378. PubMed ID: 34342437
    [Abstract] [Full Text] [Related]

  • 10. Promising Anticancer Prodrugs Based on Pt(IV) Complexes with Bis-organosilane Ligands in Axial Positions.
    Navas F, Chocarro-Calvo A, Iglesias-Hernández P, Fernández-García P, Morales V, García-Martínez JM, Sanz R, De la Vieja A, García-Jiménez C, García-Muñoz RA.
    J Med Chem; 2024 Apr 25; 67(8):6410-6424. PubMed ID: 38592014
    [Abstract] [Full Text] [Related]

  • 11. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z, Wang H, Li Y, Qin Y, Xu L, Bowers DJ, Gangoda M, Li X, Yang HB, Zheng YR.
    Chem Commun (Camb); 2018 Jan 18; 54(7):731-734. PubMed ID: 29303526
    [Abstract] [Full Text] [Related]

  • 12. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs.
    Shi H, Romero-Canelón I, Hreusova M, Novakova O, Venkatesh V, Habtemariam A, Clarkson GJ, Song JI, Brabec V, Sadler PJ.
    Inorg Chem; 2018 Nov 19; 57(22):14409-14420. PubMed ID: 30365308
    [Abstract] [Full Text] [Related]

  • 13. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V, Marzano C, Pelosi G, Ravera M, Gabano E, Osella D.
    ChemMedChem; 2014 Jun 19; 9(6):1299-305. PubMed ID: 24715720
    [Abstract] [Full Text] [Related]

  • 14. Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy.
    Tang L, Luo Y, Luo W, Sun G, Jiang Y, Zhang Z, Yue X, Li S, Liang L, Liu W, Hu J.
    Curr Protein Pept Sci; 2024 Jun 19; 25(10):797-813. PubMed ID: 38919078
    [Abstract] [Full Text] [Related]

  • 15. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q, Yang Y, Lin X, Ma W, Chen G, Li W, Wang X, Yu Z.
    Chem Commun (Camb); 2018 May 22; 54(42):5369-5372. PubMed ID: 29744485
    [Abstract] [Full Text] [Related]

  • 16. Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.
    Savino S, Gandin V, Hoeschele JD, Marzano C, Natile G, Margiotta N.
    Dalton Trans; 2018 May 29; 47(21):7144-7158. PubMed ID: 29766157
    [Abstract] [Full Text] [Related]

  • 17. Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
    Hoffmeister BR, Hejl M, Adib-Razavi MS, Jakupec MA, Galanski M, Keppler BK.
    Chem Biodivers; 2015 Apr 29; 12(4):559-74. PubMed ID: 25879501
    [Abstract] [Full Text] [Related]

  • 18. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X, Wang M, Wang C, Hu W, You Q, Yang Y, Yu C, Liao Z, Gou S, Wang H.
    Bioorg Chem; 2019 Nov 29; 92():103236. PubMed ID: 31494328
    [Abstract] [Full Text] [Related]

  • 19. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
    Novohradsky V, Zerzankova L, Stepankova J, Vrana O, Raveendran R, Gibson D, Kasparkova J, Brabec V.
    J Inorg Biochem; 2014 Nov 29; 140():72-9. PubMed ID: 25063910
    [Abstract] [Full Text] [Related]

  • 20. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs.
    Yao H, Gunawan YF, Liu G, Tse MK, Zhu G.
    Dalton Trans; 2021 Oct 12; 50(39):13737-13747. PubMed ID: 34519297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.